PRDS   $2.16  0.93% Market Closed

Pardes Biosciences Inc
Total Cash 153.20M
totalCashPerShare 2.524
EBITDA
Total Debt 0.00
quickRatio 79.583
currentRatio 81.719
Total Revenue
debtToEquity
Revenue/Share
ROA -0.26485002
ROE -0.40282002
grossProfits
freeCashflow -51.07M
operatingCashflow -78.74M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -22.10M
forwardPE -4.2352943
floatShares 14.06M
sharesOutstanding 62.01M
sharesShort 874.35K
sharesShortPriorMonth 1.04M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.72%
Short Ratio help_outline 1.09%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 2.573
Price To Book help_outline 0.84
earningsQuarterlyGrowth
netIncomeToCommon -76.14M
trailingEps -1.28%
forwardEps -0.51%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.07 3Q 2023
institutionsCount 91
lastUpdated Sept. 6, 2023, 7:42 p.m.